132 results on '"O'Donnell, Denis E."'
Search Results
2. Abnormal Exertional Breathlessness on Cardiopulmonary Cycle Exercise Testing in Relation to Self-Reported and Physiologic Responses in Chronic Airflow Limitation
3. Impaired Spirometry and COPD Increase the Risk of Cardiovascular Disease: A Canadian Cohort Study
4. Physiological underpinnings of exertional dyspnoea in mild fibrosing interstitial lung disease
5. V̇/Q̇ Mismatch: A Novel Target for COPD Treatment
6. Using Cardiopulmonary Exercise Testing to Understand Dyspnea and Exercise Intolerance in Respiratory Disease
7. Compensatory responses to increased mechanical abnormalities in COPD during sleep
8. Exercise Intolerance in Untreated OSA: Role of Pulmonary Gas Exchange and Systemic Vascular Abnormalities
9. Reference values for leg effort during incremental cycle ergometry in non‐trained healthy men and women, aged 19–85
10. Beyond Spirometry: Linking Wasted Ventilation to Exertional Dyspnea in the Initial Stages of COPD
11. The physiology and pathophysiology of exercise hyperpnea
12. Physiological Characterization of Preserved Ratio Impaired Spirometry in the CanCOLD Study: Implications for Exertional Dyspnea and Exercise Intolerance.
13. Normative Reference Equations for Breathlessness Intensity during Incremental Cardiopulmonary Cycle Exercise Testing
14. Late Breaking Abstract - Phenotyping dynamic and "static” lung volumes in COPD: implications for exertional dyspnoea and exercise tolerance
15. Late Breaking Abstract - Systemic Determinants of Exercise Intolerance in Patients with Fibrosing Interstitial Lung Disease and a Severely Impaired DLCO
16. Systemic Determinants of Exercise Intolerance in Patients With Fibrotic Interstitial Lung Disease and Severely Impaired DLCO
17. The role of the pulmonary function laboratory to assist in disease management: connective tissue diseases.
18. Short-term air pollution exposure and exacerbation events in mild to moderate COPD: a case-crossover study within the CanCOLD cohort
19. The Lancet COPD Commission: broader questions remain
20. Response
21. Systemic Determinants of Exercise Intolerance in Patients With Fibrotic Interstitial Lung Disease and Severely Impaired DLCO.
22. Impaired Spirometry and COPD Increase the Risk of Cardiovascular Disease
23. Online Data Supplement: Dynamic Ventilatory Reserve During Incremental Exercise: Reference Values and Clinical Validation in Chronic Obstructive Pulmonary Disease.
24. Dynamic Ventilatory Reserve During Incremental Exercise: Reference Values and Clinical Validation in Chronic Obstructive Pulmonary Disease.
25. Neurophysiological Mechanisms of Exertional Dyspnea in Post-Pulmonary Embolism Syndrome
26. Exercise Intolerance in Untreated OSA
27. V̇/Q̇ Mismatch
28. Reply to Jankowich: PRISm: What?s in a Name?
29. The severe asthma–obesity conundrum: Consequences for exertional dyspnoea and exercise tolerance in men and women
30. Pulmonary function laboratory to assist in the management of cardiac disease.
31. Ambient Air Pollution and Dysanapsis: Associations with Lung Function and Chronic Obstructive Pulmonary Disease in the Canadian Cohort Obstructive Lung Disease Study
32. Impaired Ventilatory Efficiency, Dyspnea, and Exercise Intolerance in Chronic Obstructive Pulmonary Disease: Results from the CanCOLD Study
33. Excess ventilation and exertional dyspnoea in heart failure and pulmonary hypertension
34. Pulmonary Vascular Volume by Quantitative CT in Dyspneic Smokers with Minor Emphysema.
35. Right ventricular dimensions during COPD exacerbations: A matter of low preload versus high afterload?
36. Exertional dyspnoea in patients with mild‐to‐severe chronic obstructive pulmonary disease: neuromechanical mechanisms.
37. Physiological predictors of morbidity and mortality in COPD: the relative importance of reduced inspiratory capacity and inspiratory muscle strength.
38. Small airway disease: when the “silent zone” speaks up.
39. Qualitative Components of Dyspnea during Incremental Exercise across the COPD Continuum.
40. Mechanisms of Exertional Dyspnea in Patients with Mild COPD and a Low Resting DLCO.
41. The role of the pulmonary function laboratory to assist in disease management: interstitial lung disease.
42. Right ventricular dimensions during COPD exacerbations: A matter of low preload versus high afterload?
43. The pulmonary function laboratory in the investigation of dyspnea of unknown origin.
44. The LancetCOPD Commission: broader questions remain
45. Probing the old lung: challenges to pulmonary function testing interpretation in the elderly.
46. Calculating the statistical limits of normal and Z-scores for pulmonary function tests.
47. Lung function: what constitutes (ab) normality?
48. Breathing too much! Ventilatory inefficiency and exertional dyspnea in pulmonary hypertension.
49. (Mis)Interpreting changes in pulmonary function tests over time.
50. Impaired spirometry and chronic obstructive pulmonary disease increase the risk of cardiovascular disease: a Canadian cohort study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.